ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
Lina Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.